Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZIVAL 2: Safety of Integrated Treatment for Trachoma and Lymphatic Filariasis
NCT01903057Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, ivermectin, albendazole in trachoma, lymphatic filariasis (LF), sponsored by Emory University. Planned start Feb 2014; status: withdrawn.
02
Drugs
azithromycinivermectinalbendazole
03
Conditions
trachomalymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT01903057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903057.